These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33181159)

  • 41. Improvement in sudden cardiac death risk prediction by the enhanced American College of Cardiology/American Heart Association strategy in Chinese patients with hypertrophic cardiomyopathy.
    Liu J; Wu G; Zhang C; Ruan J; Wang D; Zhang M; Wang L; Yang Y; Li X; Wang Y; Hui R; Zou Y; Kang L; Wang J; Song L
    Heart Rhythm; 2020 Oct; 17(10):1658-1663. PubMed ID: 32311532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disease Progression of Hypertrophic Cardiomyopathy: Modeling Using Machine Learning.
    Pičulin M; Smole T; Žunkovič B; Kokalj E; Robnik-Šikonja M; Kukar M; Fotiadis DI; Pezoulas VC; Tachos NS; Barlocco F; Mazzarotto F; Popović D; Maier LS; Velicki L; Olivotto I; MacGowan GA; Jakovljević DG; Filipović N; Bosnić Z
    JMIR Med Inform; 2022 Feb; 10(2):e30483. PubMed ID: 35107432
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management.
    Rowin EJ; Maron BJ; Haas TS; Garberich RF; Wang W; Link MS; Maron MS
    J Am Coll Cardiol; 2017 Feb; 69(7):761-773. PubMed ID: 28209216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Machine learning algorithms to automate differentiating cardiac amyloidosis from hypertrophic cardiomyopathy.
    Wu ZW; Zheng JL; Kuang L; Yan H
    Int J Cardiovasc Imaging; 2023 Feb; 39(2):339-348. PubMed ID: 36260236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
    Maron BJ; Rowin EJ; Casey SA; Lesser JR; Garberich RF; McGriff DM; Maron MS
    Circulation; 2016 Jan; 133(1):62-73. PubMed ID: 26518766
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prognostic value of standardized reference values for speckle-tracking global longitudinal strain in hypertrophic cardiomyopathy.
    Hartlage GR; Kim JH; Strickland PT; Cheng AC; Ghasemzadeh N; Pernetz MA; Clements SD; Williams BR
    Int J Cardiovasc Imaging; 2015 Mar; 31(3):557-65. PubMed ID: 25585646
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of diabetes mellitus on the clinical phenotype of hypertrophic cardiomyopathy.
    Wasserstrum Y; Barriales-Villa R; Fernández-Fernández X; Adler Y; Lotan D; Peled Y; Klempfner R; Kuperstein R; Shlomo N; Sabbag A; Freimark D; Monserrat L; Arad M
    Eur Heart J; 2019 Jun; 40(21):1671-1677. PubMed ID: 30358878
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NATURAL LANGUAGE PROCESSING BASED MACHINE LEARNING MODEL USING CARDIAC MRI REPORTS TO IDENTIFY HYPERTROPHIC CARDIOMYOPATHY PATIENTS.
    Sundaram DSB; Arunachalam SP; Damani DN; Farahani NZ; Enayati M; Pasupathy KS; Arruda-Olson AM
    Proc Des Med Devices Conf; 2021 Apr; 2021():. PubMed ID: 35463194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association Between Depression and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy.
    Hu HL; Chen H; Zhu CY; Yue X; Wang HW; Qian G; Zhai CL; He CJ
    J Am Heart Assoc; 2021 Apr; 10(8):e019071. PubMed ID: 33834850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of Major Adverse Cardiovascular Events in Patients With Hypertrophic Cardiomyopathy Using Proteomics Profiling.
    Shimada YJ; Raita Y; Liang LW; Maurer MS; Hasegawa K; Fifer MA; Reilly MP
    Circ Genom Precis Med; 2022 Dec; 15(6):e003546. PubMed ID: 36252118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of Long-Term Outcome in Children with Hypertrophic Cardiomyopathy.
    Ziółkowska L; Turska-Kmieć A; Petryka J; Kawalec W
    Pediatr Cardiol; 2016 Mar; 37(3):448-58. PubMed ID: 26526335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Texture analysis and machine learning of non-contrast T1-weighted MR images in patients with hypertrophic cardiomyopathy-Preliminary results.
    Baeßler B; Mannil M; Maintz D; Alkadhi H; Manka R
    Eur J Radiol; 2018 May; 102():61-67. PubMed ID: 29685546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of the relationship between the ambulatory electrocardiography-based micro T-wave alternans and the predicted risk score of sudden cardiac death at 5 years in patients with hypertrophic cardiomyopathy.
    Özyılmaz S; Püşüroğlu H
    Anatol J Cardiol; 2018 Sep; 20(3):165-173. PubMed ID: 30152798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.
    Chan RH; Maron BJ; Olivotto I; Pencina MJ; Assenza GE; Haas T; Lesser JR; Gruner C; Crean AM; Rakowski H; Udelson JE; Rowin E; Lombardi M; Cecchi F; Tomberli B; Spirito P; Formisano F; Biagini E; Rapezzi C; De Cecco CN; Autore C; Cook EF; Hong SN; Gibson CM; Manning WJ; Appelbaum E; Maron MS
    Circulation; 2014 Aug; 130(6):484-95. PubMed ID: 25092278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deep learning algorithm to improve hypertrophic cardiomyopathy mutation prediction using cardiac cine images.
    Zhou H; Li L; Liu Z; Zhao K; Chen X; Lu M; Yin G; Song L; Zhao S; Zheng H; Tian J
    Eur Radiol; 2021 Jun; 31(6):3931-3940. PubMed ID: 33241513
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator.
    Ruiz-Salas A; García-Pinilla JM; Cabrera-Bueno F; Fernández-Pastor J; Peña-Hernández J; Medina-Palomo C; Barrera-Cordero A; De Teresa E; Alzueta J
    Europace; 2016 May; 18(5):773-7. PubMed ID: 25855675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predicting the Risk of Adverse Events in Pregnant Women With Congenital Heart Disease.
    Chu R; Chen W; Song G; Yao S; Xie L; Song L; Zhang Y; Chen L; Zhang X; Ma Y; Luo X; Liu Y; Sun P; Zhang S; Fang Y; Dong T; Zhang Q; Peng J; Zhang L; Wei Y; Zhang W; Su X; Qiao X; Song K; Yang X; Kong B
    J Am Heart Assoc; 2020 Jul; 9(14):e016371. PubMed ID: 32662348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic significance of late gadolinium enhancement on cardiac magnetic resonance in patients with hypertrophic cardiomyopathy.
    He D; Ye M; Zhang L; Jiang B
    Heart Lung; 2018; 47(2):122-126. PubMed ID: 29174363
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Utilizing ECG-Based Heartbeat Classification for Hypertrophic Cardiomyopathy Identification.
    Rahman QA; Tereshchenko LG; Kongkatong M; Abraham T; Abraham MR; Shatkay H
    IEEE Trans Nanobioscience; 2015 Jul; 14(5):505-12. PubMed ID: 25915962
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improving the clinical understanding of hypertrophic cardiomyopathy by combining patient data, machine learning and computer simulations: A case study.
    Lyon A; Mincholé A; Bueno-Orovio A; Rodriguez B
    Morphologie; 2019 Dec; 103(343):169-179. PubMed ID: 31570308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.